Caitlin Cronin
Stock Analyst at Canaccord Genuity
(3.87)
# 667
Out of 5,120 analysts
47
Total ratings
48.57%
Success rate
13.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $105 → $112 | $89.70 | +24.86% | 3 | Jan 9, 2026 | |
| ENOV Enovis | Maintains: Buy | $58 → $50 | $22.17 | +125.53% | 4 | Dec 17, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $16.62 | -9.75% | 6 | Dec 17, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $72 → $85 | $71.25 | +19.30% | 3 | Dec 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $27 → $37 | $35.02 | +5.65% | 8 | Dec 5, 2025 | |
| TELA TELA Bio | Maintains: Buy | $7 → $4 | $0.95 | +323.28% | 5 | Nov 18, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $36 → $34 | $34.26 | -0.76% | 4 | Nov 11, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $25 | $14.49 | +72.53% | 5 | Oct 31, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $58 | $36.94 | +57.01% | 4 | Aug 1, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $8.21 | +82.70% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $5.69 | -29.70% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $130 | $86.22 | +50.78% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $2.09 | +474.16% | 1 | Nov 14, 2023 |
Globus Medical
Jan 9, 2026
Maintains: Buy
Price Target: $105 → $112
Current: $89.70
Upside: +24.86%
Enovis
Dec 17, 2025
Maintains: Buy
Price Target: $58 → $50
Current: $22.17
Upside: +125.53%
InMode
Dec 17, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $16.62
Upside: -9.75%
Establishment Labs Holdings
Dec 17, 2025
Maintains: Buy
Price Target: $72 → $85
Current: $71.25
Upside: +19.30%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $27 → $37
Current: $35.02
Upside: +5.65%
TELA Bio
Nov 18, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $0.95
Upside: +323.28%
Smith & Nephew
Nov 11, 2025
Maintains: Hold
Price Target: $36 → $34
Current: $34.26
Upside: -0.76%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $25
Current: $14.49
Upside: +72.53%
Vericel
Aug 1, 2025
Maintains: Buy
Price Target: $61 → $58
Current: $36.94
Upside: +57.01%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $8.21
Upside: +82.70%
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $5.69
Upside: -29.70%
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $86.22
Upside: +50.78%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $2.09
Upside: +474.16%